Balaxi Pharmaceuticals Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 23.61 | 26.22 | 23.52 |
| Operating Expense | 22.17 | 23.21 | 18.54 |
| Net Profit | 0.16 | 1.53 | 3.26 |
| Net Profit Margin | 0.68% | 5.84% | 13.86% |
| Earning Per Share | 0.03 | 0.28 | 0.59 |
| EBIDTA | 0.97 | 3.00 | 4.99 |
| Effective Tax Rate | -14.58% | 19.60% | 19.84% |
Particulars
Mar 2026
Revenue23.61
Operating Expense22.17
Net Profit0.16
Net Profit Margin0.68
Earning Per Share0.03
EBIDTA0.97
Effective Tax Rate-14.58
